Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Point-of-Care Glucose Testing Market Grown from 2024 to 2025?

In past years, the point-of-care glucose testing market has experienced a consistent growth. From 2024 to 2025, it is predicted to increase from $4.91 billion to $5.15 billion, exhibiting a compound annual growth rate (CAGR) of 4.9%. Reasons for the historic growth include an increasing number of diabetes cases, rising awareness related to managing diabetes, growth of the aging population, improvements in healthcare infrastructures, and a higher uptake of point-of-care testing.

What Growth Rate Is Anticipated for the Point-of-Care Glucose Testing Market in the Coming Years?

Anticipations forecast a considerable upsurge in the market size of point-of-care glucose testing in the upcoming years. With a projected compound annual growth rate (CAGR) of 6.0%, the market value will reach $6.51 billion by 2029. The surge during the forecast period is likely due to the broadening scope of telemedicine services, an increased focus on tailored medicine for diabetes treatment, the proliferation of diabetes management programs, amplified funding in glucose testing R&D, and the embracement of continuous glucose monitoring. Key trends for the projected period incorporate the evolution of wearable glucose monitoring apparatus, the merger of smartphone connectivity with glucose testing, the proliferation of point-of-care testing in domestic health care environments, the incorporation of artificial intelligence in analyzing glucose data, and the enlargement of remote patient monitoring for diabetes.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12207&type=smp

Who Are the Leading Companies in the Point-of-Care Glucose Testing Market?

Major companies operating in the point-of-care glucose testing market include F Hoffmann-La Roche Ltd., Abbott Laboratories Inc., Danaher Corporation, Siemens Healthineers, Becton, Dickinson and Company, TaiDoc Technology Corporation, B. Braun Melsungen AG, Beckman Coulter Inc., Nipro Corporation, Dexcom Inc., Bio-Rad Laboratories Inc., LifeScan Inc., Nova Biomedical Corporation, Ypsomed AG, Ascensia Diabetes Care Holdings AG, Trividia Health Inc., Radiometer Medical ApS, HemoCue AB, EKF Diagnostics Holdings plc, Trinity Biotech plc, Bionime Corporation, PTS Diagnostics, ForaCare Inc., Menarini Diagnostics, ACON Laboratories Inc., Senseonics Holdings Inc., Prodigy Diabetes Care LLC, Nemaura Medical Inc.

What Are the Key Drivers of the Point-of-Care Glucose Testing Market?

The escalation in diabetes prevalence is projected to fuel the expansion of the point-of-care glucose testing market in the near future. Defined as a chronic metabolic anomaly, Diabetes results in heightened blood glucose levels, which, over periods of time, can eventually cause severe harm to the heart, blood vessels, eyes, kidneys, and nerves. Widely in use among hospitalized patients, the point-of-care glucose testing technology enables immediate treatment decisions regarding changes in glycemia, thereby optimizing therapeutic efficacy and managing diabetes more effectively. As an example, The National Health Service (NHS England), a UK-based public health service provider, reported in June 2024 that the number of individuals identified as having pre-diabetes escalated to 3,615,330 in 2023; representing a rise of 18% from 3,065,825 in 2022. Furthermore, the cases among those under 40 soared by nearly 25%, growing from 173,166 in 2022 to 216,440 in 2023. Consequently, the rising prevalence of diabetes is contributing to the advancement of the point-of-care glucose testing market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=12207&type=smp

What Are the Key Market Segments in the Point-of-Care Glucose Testing Industry?

The point-of-care glucose testing market covered in this report is segmented –

1) By Product: Lancet And Lancing Devices, Strips, Meters

2) By Testing Site: Fingertips, Alternate Site Testing

3) By Applications: Type-1 Diabetes, Type-2 Diabetes

4) By End-User: Professional Diagnostic Centers, Hospitals And Clinics, Home Care Settings, Other End Users

Subsegments:

1) By Lancet And Lancing Devices: Single-Use Lancets, Multi-Use Lancets, Adjustable Lancing Devices

2) By Strips: Glucose Test Strips, Ketone Test Strips, Combo Strips (Glucose And Ketone)

3) By Meters: Blood Glucose Meters, Continuous Glucose Monitoring (CGM) Meters, Bluetooth-Enabled Meters

What Are the Latest Trends in the Point-of-Care Glucose Testing Market?

In the point-of-care glucose testing market, the predominant trend that is emerging is product innovation. With an aim to solidify their market standing, major companies in this sector are channeling their efforts towards the creation of ground-breaking products. An example of this is the launch of Cobas Pulse by F. Hoffmann-La Roche AG, a Swiss healthcare company, in January 2022. Catering to healthcare professionals, this new point-of-care blood glucose monitor resembles a touchscreen smartphone in design and runs various applications. Cobas Pulse features a handheld, rugged design, an automated glucose test strip reader, a camera, and a touchscreen, which can be disinfected after usage and is suitable for patients across age groups, including newborns and those in intensive care. It is designed to streamline the workflows of physicians by integrating the Glucommander dosage software into the blood glucose reader, and providing access to decision-support applications from companies like Smart4Diagnostics, CardioSignal, and SteadySense.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/point-of-care-glucose-testing-global-market-report

What Are the Key Regional Markets in the Point-of-Care Glucose Testing Industry?

North America was the largest region in the point-of-care glucose testing market in 2024. The regions covered in the point-of-care glucose testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12207

This Report Delivers Insight On:

1. How big is the point-of-care glucose testing market, and how is it changing globally?

2. Who are the major companies in the point-of-care glucose testing market, and how are they performing?

3. What are the key opportunities and risks in the point-of-care glucose testing market right now?

4. Which products or customer segments are growing the most in the point-of-care glucose testing market?

5. What factors are helping or slowing down the growth of the point-of-care glucose testing market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model